Caliber Imaging & Diagnostics, Inc. (LCDX) Research

Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.

Market snapshot

Symbol
LCDX
Price
$0.00
Day change
0.00%
Market cap
$5.1K
P/E ratio
-0.00x
52-week range
0.0001-0.0008
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • New York Health Care, Inc. (BBAL)
  • FluoroPharma Medical, Inc. (FPMI)
  • Longport, Inc. (LPTI)
  • Nemaura Medical Inc. (NMRD)
  • Net Medical Xpress Solutions, Inc. (NMXS)
  • NewCardio, Inc. (NWCI)
  • Rebus Holdings, Inc. (RBSH)
  • Urologix, Inc. (ULGX)

Recent insider activity

  • CHRISTOPHER RICHARD — trade (0 shares) on 2014-03-18
  • SHEA WILLIAM J — A-Award (500000 shares) on 2013-09-13
  • SHEA WILLIAM J — P-Purchase (214286 shares) on 2012-12-18
  • SHEA WILLIAM J — G-Gift (300000 shares) on 2012-12-19
  • SHEA WILLIAM J — G-Gift (300000 shares) on 2012-12-19

Open Caliber Imaging & Diagnostics, Inc. (LCDX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.